Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0000902664-24-004622
Filing Date
2024-07-08
Accepted
2024-07-08 17:27:01
Documents
1
Effectiveness Date
2024-07-08
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8425
  Complete submission text file 0000902664-24-004622.txt   9594
Mailing Address 750 LEXINGTON AVENUE 19TH FLOOR NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE 19TH FLOOR NEW YORK NY 10022 (212) 317-7500
Avicenna Life Sci US Fund LP (Filer) CIK: 0002028627 (see all company filings)

EIN.: 934638445 | State of Incorp.: DE
Type: D | Act: 33 | File No.: 021-518021 | Film No.: 241105861